Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIRSEVIMAB vs NITRIC: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIRSEVIMAB vs NITRIC: Safety Overview

Metric NIRSEVIMAB NITRIC
Total FAERS Reports 247 3,068
Deaths Reported 5 868
Death Rate 2.0% 28.3%
Hospitalizations 149 290
Average Patient Age 0.3 yrs 37.0 yrs
% Female Patients 42.3% 47.3%
FDA Approval Date N/A Dec 20, 2019
Manufacturer Sanofi Pasteur Inc. Airgas Therapeutics, LLC
Route INTRAMUSCULAR RESPIRATORY (INHALATION)
Marketing Status N/A Discontinued